ArticleFrontiers in research metrics and analytics2026
Use of artificial intelligence tools in the publishing process: expectations from publishers through author guidelines.
Article in Frontiers in research metrics and analytics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Writing as formation: supervising AI use in early-career medical authorship.Frontiers in artificial intelligence · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The rapid integration of artificial intelligence (AI) into scholarly publishing has prompted publishers to develop policies that guide its ethical and practical use. This study explored the question, "What do publishers expect on the use of AI as portrayed in the author guidelines and AI publisher policies?" The investigation was guided by internationally recognized frameworks, including the STM ethical and practical guidelines on AI use, the Committee on Publication Ethics, the World Association of Medical Editors (WAME) recommendations on chatbots and generative AI in scholarly publishing, and the International Committee of Medical Journal Editors (ICMJE) standards. Methods: A qualitative research approach was employed, drawing from AI-related guidelines and policies from major scholarly publishers. Four publishers were purposively selected based on their global reach, relevance across multiple disciplines, and established AI policies. Data collection was conducted through document and web content analysis, which systematically extracted relevant information from publishers' websites. Results: A qualitative research approach was employed, drawing from AI-related guidelines and policies from major scholarly publishers. Four publishers were purposively selected based on their global reach, relevance across multiple disciplines, and established AI policies. Data collection was conducted through document and web content analysis, which systematically extracted relevant information from publishers' websites. The findings revealed that AI policies are not standardized across publishers; instead, each adopts its own unique rules regarding AI-assisted writing, authorship, peer review, and disclosure. Discussion: While prior studies have documented the prevalence of disclosure requirements and authorship prohibitions, the present study moves beyond inventory to critically examine how international frameworks are reflected, adapted, and contested within individual publisher policies, and to surface tensions around enforceability, equity, and disciplinary variability that remain underexplored in existing literature. Consequently, researchers are required to carefully consult the specific policies of their target publishers before submission. The study recommends that all stakeholders in the publishing process be informed about AI-related policies relevant to their roles. Authors should ensure that AI outputs are accurate, reviewers must remain vigilant about unauthorized AI use, and publishers should proactively communicate best practices to maintain integrity and transparency in the scholarly publishing process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.